INCIDENCE OF HERPES SIMPLEX VIRUS KERATITIS AND OTHER OCULAR DISEASE: GLOBAL REVIEW AND ESTIMATES.
McCormick I, James C, Welton NJ, Mayaud P, Turner KME, Gottlieb SL, Foster A, Looker KJ.
Ophthalmic Epidemiol. 2022 Aug;29(4):353-362. doi: 10.1080/09286586.2021.1962919. Epub 2021 Oct 8.
Cataract surgery in herpes simplex virus ocular disease.
Al-Ani HH, Lu LM, Meyer JJ, Niederer RL.
J Cataract Refract Surg. 2022 Mar 1;48(3):304-309. doi: 10.1097/j.jcrs.0000000000000745.
Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?
Al-Dujaili LJ, Clerkin PP, Clement C, McFerrin HE, Bhattacharjee PS, Varnell ED, Kaufman HE, Hill JM.
Future Microbiol. 2011 Aug;6(8):877-907. doi: 10.2217/fmb.11.73.
Herpes simplex virus epidemiology and ocular importance.
Liesegang TJ.
Cornea. 2001 Jan;20(1):1-13. doi: 10.1097/00003226-200101000-00001.
Deep Herpes.
Krystel-Whittemore M, Chan MP, Shalin SC, Sauder KJ, Hudson A, Foreman RK, Hoang MP, Brennick JB, Yan S, Nazarian RM.
Am J Surg Pathol. 2021 Oct 1;45(10):1357-1363. doi: 10.1097/PAS.0000000000001733.
Rates of Herpes Simplex Virus Types 1 and 2 in Ocular and Peri-ocular Specimens.
Meyer JJ.
Ocul Immunol Inflamm. 2023 Jan;31(1):149-152. doi: 10.1080/09273948.2021.1998548. Epub 2021 Nov 22.
A tissue-targeted prime/pull/keep therapeutic herpes simplex virus vaccine protects against recurrent ocular herpes infection and disease in HLA-A*0201 transgenic rabbits.
Chentoufi AA, Prakash S, Vahed H, Karan S, Quadiri A, Nesburn AB, BenMohamed L.
J Virol. 2025 May 20;99(5):e0013525. doi: 10.1128/jvi.00135-25. Epub 2025 Apr 10.
Herpes Simplex Virus 1 Replication, Ocular Disease, and Reactivations from Latency Are Restricted Unilaterally after Inoculation of Virus into the Lip.
Poccardi N, Rousseau A, Haigh O, Takissian J, Naas T, Deback C, Trouillaud L, Issa M, Roubille S, Juillard F, Efstathiou S, Lomonte P, Labetoulle M.
J Virol. 2019 Nov 26;93(24):e01586-19. doi: 10.1128/JVI.01586-19. Print 2019 Dec 15.
Regulation of herpes simplex virus type 1 latency-reactivation cycle and ocular disease by cellular signaling pathways.
Harrison KS, Jones C.
Exp Eye Res. 2022 May;218:109017. doi: 10.1016/j.exer.2022.109017. Epub 2022 Mar 1.
Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.
Pavan-Langston D.
Trans Am Ophthalmol Soc. 1990;88:727-96.
